Tectonic Therapeutic, Inc.
TECX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $294 | $371 | $304 | $683 |
| - Cash | $268 | $287 | $306 | $141 |
| + Debt | $1 | $2 | $3 | $3 |
| Enterprise Value | $26 | $86 | $0 | $545 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$19 | -$19 | -$16 | -$12 |
| % Margin | – | – | – | – |
| Net Income | -$19 | -$20 | -$16 | -$12 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.02 | -1.07 | -0.93 | -0.84 |
| % Growth | 4.7% | -15.1% | -10.7% | – |
| Operating Cash Flow | -$18 | -$15 | -$13 | -$17 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$18 | -$15 | -$13 | -$17 |